Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of Subconjunctival Injection of Bevacizumab (Avastin) in the Treatment of Corneal Neovasculization

NCT00681603 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00681603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00681603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of Subconjunctival Injection of Bevacizumab (Avastin) in the Treatment of Corneal Neovasculization
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
February 29, 2008
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpetic keratopathy, lipid keratopathy, penetrating keratoplasty, rosacea